In case you missed it: March 8 to March 12
It was a very busy week for the Contemporary OB/GYN team.
This week’s top articles included:
How insurance impacts access to NIPT
Some women are unable to choose noninvasive prenatal testing (NIPT), due to lack of insurance coverage, according to a pilot study in the Journal of Community Genetics.
Cost of cell-free DNA noninvasive testing for Down syndrome
A small percentage of women whose noninvasive prenatal testing (NIPT) results were negative regretted taking the test and blamed themselves, according to a 1-year postpartum questionnaire survey.
Inclusion necessary in clinical trials
This month’s issue brings with it hope for a spring season that will see an easing of COVID-19 cases and deaths, despite new virus mutations.
Improvements in Research Needed for Reproductive Health of Transgender and Gender Diverse People
The scoping review revealed target areas that require additional research, as well as a need for more variety in study designs, populations, and locations.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
